Waters (NYSE:WAT) Issues FY 2025 Earnings Guidance

Waters (NYSE:WAT) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 12.700-13.000 for the period, compared to the consensus EPS estimate of 12.830. The company issued revenue guidance of $3.0 billion-$3.1 billion, compared to the consensus revenue estimate of $3.1 billion. Waters also updated its Q1 2025 guidance to 2.170-2.250 EPS.

Waters Stock Down 7.5 %

Shares of WAT traded down $30.60 during mid-day trading on Wednesday, reaching $374.69. The company’s stock had a trading volume of 506,772 shares, compared to its average volume of 416,838. The company has a market cap of $22.25 billion, a price-to-earnings ratio of 35.56, a price-to-earnings-growth ratio of 7.37 and a beta of 1.01. The business has a fifty day moving average of $390.34 and a 200 day moving average of $363.72. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. Waters has a 1 year low of $279.24 and a 1 year high of $423.56.

Waters (NYSE:WAT) last announced its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 49.93% and a net margin of 21.43%. As a group, analysts forecast that Waters will post 11.79 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on WAT. TD Cowen upped their price target on Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Wells Fargo & Company raised their target price on shares of Waters from $380.00 to $415.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Barclays raised shares of Waters from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $360.00 to $415.00 in a research report on Monday. Cfra set a $389.00 price target on Waters in a research report on Thursday, October 17th. Finally, Stifel Nicolaus boosted their price objective on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Ten investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Waters currently has a consensus rating of “Hold” and a consensus target price of $388.64.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.